COST vs KVUE
COST: A global membership-only warehouse operator that generates consistent growth by selling high-quality products at low margins to a loyal, renewing member base. KVUE: Kenvue is a pure-play consumer health giant managing a portfolio of iconic, science-backed brands across personal care, skin health, and essential household wellness products.
Side-by-side fundamentals
| Metric | COST | KVUE | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $998.31 | $19.04 | |
| Market cap | $442.4B | $36.6B | |
| P/E as of 2026-10-21 | 48.09 | 22.40 | KVUE lower |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2026 | 3.54 | n/a | |
| Net margin | +3.0% | +9.7% | KVUE higher |
| Gross margin FY2025, SEC XBRL | n/a | +58.1% | |
| Operating margin | +3.9% | +16.0% | KVUE higher |
| ROE | +25.8% | +13.7% | COST higher |
| ROA | +10.4% | +5.4% | COST higher |
| Debt / equity | 0.17 | 0.80 | COST lower |
| Revenue growth (YoY) | +10.1% | -2.1% | COST higher |
| Revenue CAGR (3y) SEC XBRL | +7.8% | +0.2% | COST higher |
| Dividend yield as of 2026-09-03 | +0.7% | +4.7% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 2 | 3 | KVUE higher |
| Beta as of 2026-09-03 | 0.32 | 0.18 | |
| 1-year return as of 2026-10-21 close | +6.5% | +27.5% | KVUE higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.